Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.010
Sell
RSI(14)
34.680
Neutral
STOCH(KDJ)(9,3,3)
48.166
Neutral
ATR(14)
0.054
High Vlolatility
CCI(14)
-270.854
Oversold
Williams %R
57.137
Sell
TRIX(12,20)
-0.642
Sell
StochRSI(14)
8.929
Sell
Search
Aptorum Group Ltd
APMAdd to Watchlist
0.700USD
0.0000.00%
Close 07-17 16:00（ET）Quotes delayed by 15 min
32.44MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
0.00%
1 Month
-10.51%
6 Months
-26.07%
Year to Date
-33.96%
1 Year
-54.84%
Key Figures
--Open
0.000High
0.00Volume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
2.40%Turnover Ratio
0.700Prev. Close
0.000Low
0.00Turnover
LossP/E Static
-0.08P/B
0.00%Div Yield TTM
-22.61%ROA
4.47052wk High
1.26Volume Ratio
-4.27MNet Profit
8.14MShares
-0.1854EPS TTM
0.06Beta
-18.56%ROE
0.65052wk Low
21.52%Amplitude
--Gross Margin
32.44MMarket Cap
1.37Reward/Risk
6.96%Risk Rate
Aptorum Group Ltd News
More news coming soon, stay tuned...
Indicators
Moving Average
Indicators
Value
Direction
MA5
0.767
Sell
MA10
0.775
Sell
MA20
0.790
Sell
MA50
0.859
Sell
MA100
0.870
Sell
MA200
1.076
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Aptorum Group Ltd Info
Aptorum Group Limited is a United Kingdom-based clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Its lead projects are ALS-4, SACT-1 and PathsDx Test. ALS-4 is a small drug molecule which appears to target the products produced by bacterial genes that facilitate the successful colonization and survival of the bacterium in the body or that cause damage to the body's systems. SACT-1 is the first repurposed drug candidate to be developed under the Smart-ACT drug discovery platform. The Company's pipeline is also enriched through the co-development of PathsDx Test, a molecular-based rapid pathogen identification and detection diagnostics technology, with Accelerate Technologies Pte Ltd, the commercialization arm of the Singapore's Agency for Science, Technology and Research.
Ticker SymbolAPM
CompanyAptorum Group Ltd
CEOHuen (Ian)
Websitehttps://www.aptorumgroup.com/
Shareholders
Related Instruments
-0.53%
+0.27%
-2.51%
+0.32%
-1.45%
-0.92%
-0.64%
-0.82%
-8.79%
+0.52%
+0.68%
-0.95%
-0.71%
+0.44%
-1.08%
+3.29%
0.00%
-0.90%
+1.30%
-2.15%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Aptorum Group Ltd (APM)?
The current price of Aptorum Group Ltd (APM) is 0.70.
What is the symbol of Aptorum Group Ltd?
The ticker symbol of Aptorum Group Ltd is APM.
What is the 52-week high of Aptorum Group Ltd?
The 52-week high of Aptorum Group Ltd is 4.47.
What is the 52-week low of Aptorum Group Ltd?
The 52-week low of Aptorum Group Ltd is 0.65.
What is the market capitalization of Aptorum Group Ltd?
The market capitalization of Aptorum Group Ltd is 32.44M.
What is the Earnings Per Share (EPS TTM) of Aptorum Group Ltd (APM)?
The Earnings Per Share (EPS TTM) of Aptorum Group Ltd (APM) is -0.19.